IBS: Symptoms, Diagnosis, and Treatment in Australia

The symptoms of IBS vary considerably between individuals, which is one of the reasons it can take time to reach a clear diagnosis. Some people experience a dominant pattern from the outset. Others find that their symptoms shift over time, making it harder to pin down what is happening.

Abdominal pain and cramping are the defining features of the condition. The pain is typically felt in the lower abdomen and often improves after a bowel movement. It may come in waves or be relatively constant on difficult days. Many people describe it as a cramping or squeezing sensation. The intensity ranges from mild discomfort to pain that genuinely disrupts daily activities, work, and sleep.

Bloating and abdominal distension are reported by the majority of people with IBS and are frequently described as one of the most bothersome symptoms. The sensation of fullness or tightness in the abdomen can occur after eating or build over the course of the day. Visible swelling of the abdomen is common and can be significant enough to affect clothing choices, a seemingly small detail that speaks to how much this condition affects everyday life.

Changes in bowel habits are central to the diagnosis. For some people, this means frequent loose stools and urgency. For others, it means infrequent bowel movements, straining, and a sense of incomplete evacuation. Many people alternate between the two, which can make it difficult to identify a consistent pattern. Mucus in the stool is another feature that is reported with some regularity.

Gas and flatulence are common and can be socially distressing. The gut in IBS tends to produce and retain gas at higher levels than normal, contributing to both bloating and discomfort. Nausea is also reported by some people with IBS, though it is not part of the formal diagnostic criteria.

Fatigue and difficulty sleeping frequently accompany IBS. A 2017 study indexed on PubMed found that fatigue was reported by over 50 per cent of people with IBS and was independently associated with reduced quality of life. The relationship between disrupted sleep and gut symptoms appears to be bidirectional, with each making the other worse.

Anxiety and low mood are more common among people living with IBS. This is not to say that IBS is caused by anxiety. Rather, the gut-brain axis means that psychological wellbeing and digestive function influence each other. Healthdirect Australia notes that stress and emotional factors can worsen IBS symptoms, and conversely, living with chronic gut symptoms can understandably affect mental health.

The key thing to understand is that symptoms tend to fluctuate. There may be periods of relative calm followed by flare-ups that seem to come from nowhere. Identifying patterns and triggers, which we will cover next, is one of the most useful things someone with IBS can do.

One of the most frustrating aspects of IBS is that triggers vary from person to person. What causes a flare-up for one individual may be perfectly well tolerated by another. That said, research has identified several categories of triggers that are commonly reported.

Food and Dietary Triggers

Diet plays a significant role for many people with IBS. The Gastroenterological Society of Australia identifies several food groups that are commonly associated with symptom flare-ups:

• High-FODMAP foods: FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides, and polyols) are short-chain carbohydrates that are poorly absorbed in the small intestine. When they reach the large intestine, they are fermented by gut bacteria, producing gas and drawing water into the bowel. Common high-FODMAP foods include onions, garlic, wheat, certain fruits (apples, pears, watermelon), legumes, and dairy products containing lactose.
• Fatty and fried foods: High-fat meals can stimulate stronger contractions in the colon, which may trigger cramping and diarrhoea in sensitive individuals.
• Caffeine and alcohol: Both can stimulate gut motility and irritate the bowel lining. Coffee is a particularly common trigger, even in people who have consumed it without issue for years.
• Artificial sweeteners: Sorbitol, mannitol, and xylitol, which are polyols included in the FODMAP group, are found in sugar-free products and can contribute to bloating and diarrhoea.

It is worth emphasising that food triggers are not the same as food allergies. IBS is not an immune-mediated response to food. The symptoms are driven by how the gut processes and reacts to certain types of carbohydrates, fats, and stimulants. This distinction matters because it shapes the approach to management.

Stress and Psychological Triggers

The gut-brain connection is well established in IBS research. Acute stress, ongoing work or life pressures, and periods of emotional difficulty can all amplify gut symptoms. The Royal Australian College of General Practitioners notes that addressing psychological wellbeing is a legitimate and evidence-based component of IBS management. This does not mean that IBS is "all in someone's head." It means the nervous system pathways that regulate gut function are sensitive to stress signals, and managing those signals can help reduce symptom severity.

Hormonal Fluctuations

Many women report that their IBS symptoms worsen around menstruation. Research suggests that fluctuations in oestrogen and progesterone can influence gut motility and visceral sensitivity. This hormonal link may partly explain why IBS is diagnosed more frequently in women than in men.

Medications and Illness

Certain medications, including some antibiotics and non-steroidal anti-inflammatory drugs, can disrupt the gut microbiome or irritate the bowel lining, potentially triggering or worsening IBS symptoms. Episodes of gastroenteritis can also precede the onset of IBS, a phenomenon known as post-infectious IBS, which is recognised in the medical literature and estimated to account for roughly 10 per cent of IBS cases.

The Low-FODMAP Diet

The low-FODMAP diet, developed by researchers at Monash University in Melbourne, is the most extensively studied dietary intervention for IBS. It has been shown in multiple randomised controlled trials to reduce symptoms in approximately 75 per cent of people with IBS, according to data published by Monash University's FODMAP research team.

The diet is structured in three phases:

1. Elimination phase (2 to 6 weeks): All high-FODMAP foods are removed from the diet to establish a baseline of symptom relief.
2. Reintroduction phase (6 to 8 weeks): Individual FODMAP groups are systematically reintroduced one at a time, in controlled amounts, to identify which specific groups trigger symptoms.
3. Personalisation phase (ongoing): Based on what has been learned during reintroduction, a long-term eating plan is developed that avoids only the specific triggers identified, while including as wide a variety of foods as possible.

This structured approach is central to the diet's effectiveness. Simply removing all FODMAPs indefinitely is not recommended, as it can lead to nutritional gaps and may negatively affect the diversity of gut bacteria. The RACGP recommends that the low-FODMAP diet be undertaken with the guidance of an accredited practising dietitian, particularly during the elimination and reintroduction phases.

Monash University provides a smartphone app that serves as a practical reference for FODMAP content in foods, which many people find helpful as a day-to-day tool alongside professional dietary guidance.

Fibre Supplementation

Soluble fibre, such as psyllium husk (sold in Australia under brand names like Metamucil), may help manage IBS symptoms, particularly in people with constipation-predominant IBS. The Gastroenterological Society of Australia notes that soluble fibre can help regulate stool consistency and reduce bloating when introduced gradually. Insoluble fibre, such as wheat bran, can sometimes worsen bloating and cramping and is generally not recommended as a first-line fibre supplement for IBS.

Probiotics

The role of probiotics in IBS management is an area of active research. Some specific strains have shown modest benefit in clinical trials, particularly for reducing bloating and improving overall symptom scores. However, the evidence is not yet strong enough for clinical guidelines to recommend specific probiotic products universally for IBS. The Gastroenterological Society of Australia suggests that probiotics may be worth trialling on an individual basis, with the understanding that what works for one person may not work for another. Discussing this with a GP before starting a probiotic is a sensible step.

Medications

Several medications may be prescribed by a GP depending on the subtype and severity of IBS:

• Antispasmodics (such as hyoscine butylbromide and mebeverine) can help reduce abdominal cramping and pain by relaxing the smooth muscle of the gut wall. They are commonly used as needed during flare-ups.
• Laxatives may be recommended for constipation-predominant IBS when dietary measures alone have not been sufficient. Osmotic laxatives are generally preferred over stimulant laxatives for regular use.
• Anti-diarrhoeal medications such as loperamide can help manage diarrhoea-predominant symptoms. They are typically used situationally rather than as a daily treatment.
• Low-dose antidepressants: Tricyclic antidepressants at low doses have evidence supporting their use in IBS, particularly for pain management. They work by modulating the gut-brain signalling pathways rather than by treating depression per se. SSRIs may also be considered in some cases. These medications require a prescription and should be discussed thoroughly with a GP.

All medication decisions are made by a GP based on individual circumstances, symptom patterns, and medical history. There is no one-size-fits-all pharmacological approach to IBS.

Psychological Therapies

Given the well-established role of the gut-brain axis in IBS, psychological therapies are recognised as effective management tools. Cognitive behavioural therapy (CBT) tailored for IBS has strong evidence supporting its effectiveness in reducing symptom severity and improving quality of life. Gut-directed hypnotherapy, developed at Monash University and other centres, has also demonstrated significant benefits in clinical trials. These approaches are recommended by the RACGP and Healthdirect as part of a comprehensive management plan for people whose symptoms are not fully controlled by dietary and pharmacological measures alone.